Free Trial

ReposiTrak (NYSE:TRAK) CEO Sells $69,560.00 in Stock

ReposiTrak logo with Computer and Technology background

Key Points

  • Randall Fields, CEO of ReposiTrak, sold 4,000 shares on September 23rd for a total of $69,560, reducing his ownership by 5.80%.
  • After the sale, Fields retains 65,000 shares valued at approximately $1,130,350.
  • Institutional investors, including Ashford Capital Management and Coldstream Capital Management, have significantly increased their holdings in ReposiTrak during the second quarter.
  • Five stocks to consider instead of ReposiTrak.

ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall Fields sold 4,000 shares of the stock in a transaction that occurred on Tuesday, September 23rd. The stock was sold at an average price of $17.39, for a total transaction of $69,560.00. Following the transaction, the chief executive officer owned 65,000 shares in the company, valued at approximately $1,130,350. The trade was a 5.80% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

ReposiTrak Stock Performance

Shares of NYSE TRAK traded down $0.30 during trading hours on Tuesday, hitting $17.15. 48,283 shares of the stock were exchanged, compared to its average volume of 50,697. The company has a current ratio of 6.03, a quick ratio of 6.03 and a debt-to-equity ratio of 0.01. The firm has a market cap of $313.50 million, a P/E ratio of 50.44 and a beta of 0.47. The firm has a fifty day moving average of $17.02. ReposiTrak Inc. has a 1-year low of $15.12 and a 1-year high of $25.01.

Institutional Trading of ReposiTrak

Several large investors have recently made changes to their positions in TRAK. Ashford Capital Management Inc. boosted its position in ReposiTrak by 93.7% in the second quarter. Ashford Capital Management Inc. now owns 792,154 shares of the company's stock valued at $15,566,000 after buying an additional 383,283 shares in the last quarter. Tower Research Capital LLC TRC raised its stake in ReposiTrak by 397.3% during the second quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company's stock worth $71,000 after buying an additional 2,892 shares during the last quarter. BNP Paribas Financial Markets grew its holdings in ReposiTrak by 63.5% in the second quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company's stock worth $32,000 after purchasing an additional 634 shares during the period. Jane Street Group LLC acquired a new position in shares of ReposiTrak during the second quarter valued at about $802,000. Finally, Coldstream Capital Management Inc. raised its position in ReposiTrak by 47,619.0% in the second quarter. Coldstream Capital Management Inc. now owns 20,042 shares of the company's stock worth $394,000 after acquiring an additional 20,000 shares during the period. Institutional investors and hedge funds own 27.35% of the company's stock.

ReposiTrak Company Profile

(Get Free Report)

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.

Featured Articles

Insider Buying and Selling by Quarter for ReposiTrak (NYSE:TRAK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in ReposiTrak Right Now?

Before you consider ReposiTrak, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.

While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.